Protein expression signature distinguishes early from late stage diffuse alveolar damage medrxivpreprint UniOfYork SARSCoV2 COVID19 DAD DiffuseAlveolarDamage
By Tarun Sai LomteDec 15 2022Reviewed by Aimee Molineux In a recent study posted to medRxiv* preprint server, researchers identified a protein expression signature that can distinguish early diffuse alveolar damage from late DAD in coronavirus disease 2019 patients.
Subjects were selected based on the histological evidence of DAD without additional complications related to pneumonia or cardiac failure. For spatial profiling, 4 μm-thick formalin-fixed paraffin-embedded sections were used. Slides were stained with cluster of differentiation 68 and CD3 as morphological markers and with a panel of 68 oligonucleotide-conjugated antibodies.
Next, the authors applied partial least-squares regression to identify those responsible for group segregation. Eight proteins were identified that largely reproduced what was noted with PCA and were used for classifying ROIs in a PLS linear discriminate analysis with leave-one-patient-out cross-validation. This yielded 93% predictive accuracy for EDAD and 80% for ODAD.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
What influence has COVID-19 vaccination had on sperm characteristics?What influence has COVID-19 vaccination had on sperm characteristics? COVID19 SARSCoV2 Coronavirus MensHealth SpermCharacteristics
Consulte Mais informação »
Evaluation of Cancer Deaths Attributable to Tobacco in California, 2014-2019This cohort study evaluates the proportion and number of cancer deaths attributable to tobacco use using patient-level data in California.
Consulte Mais informação »
Freddie Flintoff taken to hospital after accident while filming Top GearThe BBC has confirmed that Freddie Flintoff was taken to hospital on Tuesday morning after being involved in an accident while working on Top Gear.
Consulte Mais informação »
Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse modelObesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model Diabetes Efficacy Obesity Type2Diabetes Vaccine Coronavirus Disease COVID biorxivpreprint BostonChildrens harvardmed UMmedschool DanaFarber broadinstitute
Consulte Mais informação »
Polymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodiesPolymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodies ImmunityCP karolinskainst polymorphism gene genetics SARSCoV2 coronavirus covid antibody antibodies
Consulte Mais informação »